Contact

EN

中文 English

中文 English

Press

News & Insights

June 22, 2026

Hankang Portfolio | TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma Valued up to $985 Million
April 27, 2026

Hankang Portfolio | Huahui Health and BeOne Medicines Enter into a Global Exclusive Option, License and Collaboration Agreement for Innovative Oncology Drug HH160
March 26, 2026

Hankang Portfolio | Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trials

For any investor inquiries, please feel free to contact us.

Want to learn more about technical information?
Hongkong Shanghai Beijing

Copyright 2026 © Hankang All Rights Reserved.